| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |